United-Guardian 将来の成長
Future 基準チェック /06
現在、 United-Guardianの成長と収益を予測するのに十分なアナリストの調査がありません。
主要情報
n/a
収益成長率
n/a
EPS成長率
| Personal Products 収益成長 | 32.6% |
| 収益成長率 | n/a |
| 将来の株主資本利益率 | n/a |
| アナリストカバレッジ | None |
| 最終更新日 | n/a |
今後の成長に関する最新情報
Recent updates
What United-Guardian, Inc.'s (NASDAQ:UG) 25% Share Price Gain Is Not Telling You
United-Guardian, Inc. ( NASDAQ:UG ) shares have had a really impressive month, gaining 25% after a shaky period...United-Guardian (NASDAQ:UG) Has Announced A Dividend Of $0.25
United-Guardian, Inc. ( NASDAQ:UG ) has announced that it will pay a dividend of $0.25 per share on the 17th of...United-Guardian (NASDAQ:UG) Will Be Looking To Turn Around Its Returns
What financial metrics can indicate to us that a company is maturing or even in decline? A business that's potentially...Here's What's Concerning About United-Guardian's (NASDAQ:UG) Returns On Capital
Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...United-Guardian (NASDAQ:UG) Has Some Difficulty Using Its Capital Effectively
If you're looking at a mature business that's past the growth phase, what are some of the underlying trends that pop...United-Guardian, Inc. (NASDAQ:UG) Not Doing Enough For Some Investors As Its Shares Slump 29%
United-Guardian, Inc. ( NASDAQ:UG ) shareholders won't be pleased to see that the share price has had a very rough...These Return Metrics Don't Make United-Guardian (NASDAQ:UG) Look Too Strong
If we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? Businesses...Earnings Not Telling The Story For United-Guardian, Inc. (NASDAQ:UG) After Shares Rise 26%
United-Guardian, Inc. ( NASDAQ:UG ) shares have continued their recent momentum with a 26% gain in the last month...United-Guardian's (NASDAQ:UG) Upcoming Dividend Will Be Larger Than Last Year's
The board of United-Guardian, Inc. ( NASDAQ:UG ) has announced that the dividend on 31st of July will be increased to...Subdued Growth No Barrier To United-Guardian, Inc.'s (NASDAQ:UG) Price
There wouldn't be many who think United-Guardian, Inc.'s ( NASDAQ:UG ) price-to-earnings (or "P/E") ratio of 18.2x is...United-Guardian (NASDAQ:UG) Has Some Difficulty Using Its Capital Effectively
When researching a stock for investment, what can tell us that the company is in decline? Businesses in decline often...United-Guardian: Solid Balance Sheet, Solid Dividend, Strong Potential Upside
Summary Temporary setbacks have given investors a great entry point before recovery in the company's segments. New markets and potential dividend increases could be a boon to the share price over the next few years. United-Guardian's balance sheet is in spectacular order, and the businesses operate in resilient markets. Read the full article on Seeking AlphaReturns On Capital Signal Difficult Times Ahead For United-Guardian (NASDAQ:UG)
If you're looking at a mature business that's past the growth phase, what are some of the underlying trends that pop...United-Guardian, Inc.'s (NASDAQ:UG) Share Price Is Matching Sentiment Around Its Earnings
With a price-to-earnings (or "P/E") ratio of 12.8x United-Guardian, Inc. ( NASDAQ:UG ) may be sending bullish signals...Calculating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)
Key Insights Using the 2 Stage Free Cash Flow to Equity, United-Guardian fair value estimate is US$6.94 With US$7.40...Estimating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)
Key Insights The projected fair value for United-Guardian is US$9.07 based on 2 Stage Free Cash Flow to Equity...United-Guardian (NASDAQ:UG) Is Achieving High Returns On Its Capital
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...Why We Like The Returns At United-Guardian (NASDAQ:UG)
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Calculating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)
How far off is United-Guardian, Inc. ( NASDAQ:UG ) from its intrinsic value? Using the most recent financial data...Buying Back Into United-Guardian, Inc.
Since I took my chips off the table a few months back, the shares have lost over 1/3 of their value. This has put the company back on my radar. The company is less profitable, to be sure, but the dividend is reasonably well-supported, and the yield is high. This gives investors time to wait for a turnaround. We're told to "buy when others are fearfully selling." This is easier said than done, and I think United-Guardian is an example of this phenomenon. If you've got a vague inkling that the only reason I write on this platform is to brag publicly, get ready for that inkling to be massively reinforced, because today will see some industrial-grade bragging on my part. I'll try (unsuccessfully) to ignore this annoying little voice in my head yammering something about "pride goeth the fall" or whatever, so I can focus on writing about the latest win. As I pointed out in my latest piece about United-Guardian, Inc. (UG). I had outperformed the S&P 500 slightly over the previous four years, but it was time to take chips off the table. I did that this past April, and since then the shares are down about 36%. So, to drive the point home, in 2018 I was bullish on this stock and rode it to a great return. This past April I sold shares, and they've lost over ⅓ of their value since. I want to revisit this name primarily to brag, obviously, but I think there are some other reasons to revisit the name. Specifically, the company has posted financial results since I last looked at the company, and those deserve commentary. Additionally, a stock trading at $15.50 is much less risky an investment than the same stock trading at $24.50, so it may be worth buying back in at this point. I'm self-aware enough to realise that my writing can be tiresome to many. I spell words properly, and that may bother some of my American audience, with their, uh, "singular" approach to the English language. Worse, I can be a tiresome braggart, as I've already demonstrated above. This may offer some clues about the current state of my social life. Anyway, whatever the reason, I fully understand that you may not want to douse yourself in undiluted "Doyle mojo." For that reason, I offer up a "thesis statement" paragraph in each of my articles. This gives you the highlights of my argument without needing to wade through the swamp that is a full-blown article. You're welcome. Here goes. I'll be buying back into this company this morning because the shares are now sufficiently cheap again. I'm doing this in spite of the recent drop in profitability. I think the dividend is reasonably well covered, and I think the high dividend yield will be supportive of price, suggesting very limited downside from here. That said, even if the shares drop in price from the current level, the dividend will compensate for any losses over time in my view. I like investments where time is your friend, and that is certainly the case here. There you have it. If you continue to read from this point, any resulting nausea that my writing produces is on you. Company Background & Risks In case you're unfamiliar with United-Guardian, I'll do my best to enlighten you. The company operates in four distinct product categories: cosmetic ingredients, pharmaceuticals, medical products, and specialty industrial products, and each of these is marketed slightly differently. In all four categories, the company is focused on R&D activities, as evidenced by the fact that it's been granted 30 patents since its founding in 1942. The R&D efforts in the cosmetic ingredients space have been directed toward formulating "natural" products that are used as components of various cosmetic products that are then included in the formulations produced by marketing partners. The company sells its cosmetic ingredients through 5 marketing partners, the largest of which is Ashland Specialty Ingredients. These partnerships are ideal because partners have much deeper market penetration and reach than the company could achieve. The "cosmetic ingredients" category is the company's largest (~49% of sales) and fastest growing, and it is the group of products that I'm most excited about. In particular, I have high hopes for the Lubrajel suite of products. I think the macro background is quite favourable, because the demand for "natural" products is expected to grow somewhere between a healthy 5.3% and an eye-watering 6.6% pace over the next 8 years. There are two risks that I've been able to identify here. The first of these is the currency. Although fully 80% of sales take place in the United States, the stronger U.S. dollar will inevitably impact sales going forward. The next risk involves the company's ability to obtain raw materials. They have consistently been able to acquire what they needed, even during the height of the pandemic, some materials are now more expensive, and there are now longer lead times for some of them. The rising dollar and increased costs may obviously impact the company's gross profit margin on certain products. Financial Snapshot Relative to the first six months of 2021, the financial performance during the most recent period has obviously been mixed. Revenue during the first six months of the year saw sales up by about 6% compared to 2021, but net income has collapsed, down by ~$981 thousand, or 39%. The reason for this relates to increased costs of sales, operating expenses, and R&D expenses, each up by 19%, 20.3%, and 11.74% respectively. Additionally, the company took an $854 thousand dollar loss on marketable securities. The capital structure also deteriorated fairly significantly relative to the same period in 2021, with total liabilities up by ~15%, and cash down by about 21.5%. While I like making comparisons from one period to the next, it's sometimes troubling because one or both periods may not be representative. For instance, you may remember that there was a global pandemic in 2020-2021 that turned off global economic activity, and thus any comparisons to that period may be fraught with bias. For that reason, I also want to draw a comparison between the most recent period and the first six months of 2019, as the latter period is free of the pernicious effects of the pandemic. When compared to 2019, similar themes emerge. Revenue was higher and net income was lower in 2022, and the capital structure in 2022 was also much weaker. Given the above, I think it's reasonable to suggest that a part of the stock price weakness relates to the drop-off in income. One thing that buoys the stock price, though, is the dividend, and so I want to write briefly about it. If the dividend is reasonably secure, and the valuation is low enough, I'd be very happy to buy back in. The company generated $1.164 million in cash from operations during the first six months of 2022, compared to $2.6 million during the same period in 2021. The reason for the drop obviously relates to a drop in net income, but there are two other factors worth noting. First, the company spent $317.4 thousand on new inventories and spent $231.4 thousand in prepaid taxes. I think these will either add to future cash inflows, or at least reduce future outflows. During the same period, the company spent $1,699.392 on dividends, or about $535,000 more than it generated in cash from operations. It's also relevant that the company has $355 thousand in cash and approximately $6.4 million in marketable securities. Finally, although I moaned about "deterioration" above, I think it's worth noting that "cash and marketable securities" is still over 3x greater than "total liabilities." Thus, I'm reasonably confident that the dividend can be maintained here, and for that reason, I'd be happy to buy back in at the right price. United-Guardian Financials (United-Guardian Investor Relations) The Stock If you read my stuff regularly you know what time it is. It's the time where I turn into a bit of a financial "hall monitor", where I remind everyone that a company is distinct from its stock. The company buys inputs and sells them (ideally) at a profit. In the final analysis, that's all any company is. The stock, on the other hand, is a piece of paper that gets traded around in a public market and is influenced by a great many factors, many of which are only peripherally related to the underlying business. For instance, the stock price is certainly impacted by the company's recent financial performance. It's also impacted by the crowd's ever-changing views about the company's future financial performance. It's also potentially impacted by the changing moods of an influential analyst. Finally, the stock is influenced by the crowd's ever-changing perspectives on the relative merits of "stocks" as an asset class. For these reasons, the stock is a much more volatile thing than the underlying business. While this is tiresome, it is potentially profitable. If we can spot the discrepancies between the crowd's take on a given business, and the assumptions embedded in the price, we can earn a profit. Although I'm very, very sorry to circle back on this point, I bought when the market for these shares became excessively pessimistic years ago, and sold when the market became excessively optimistic. That was a lie. I wasn't at all sorry about reminding you of my success with this one. I really, really hope you forgive me. Anyway, I've found that cheaper stocks offer a higher risk-adjusted return, so I like to buy shares when I consider them to be cheap and eschew them when they get expensive. If you're one of my regular reader-victims you know that I measure the cheapness (or not) of a stock in a few ways, ranging from the simple to the more complex. On the simple side, I look at the ratio of price to some measure of economic value like sales, earnings, free cash flow, and the like. Ideally, I want to see a stock trading at a discount to both its own history and the overall market. In my previous missive, I took profits here because the price to free cash reached 22.5 times. The shares are now about 25% cheaper on that basis per the following: UG data by YCharts While the shares are relatively cheaper, investors are (unsurprisingly) being compensated with a much higher dividend yield, per the following: UG data by YChartsUnited-Guardian (NASDAQ:UG) Will Pay A Smaller Dividend Than Last Year
United-Guardian, Inc. ( NASDAQ:UG ) is reducing its dividend to US$0.37 on the 1st of Junewhich is 23% less than last...United-Guardian: Pristine Balance Sheet, Nice Dividend, But Fully Valued
We advised the subscribers to our research to buy dividend-paying United-Guardian at $14 per share in July 2020 for their income portfolio. United-Guardian has paid dividends since 1999, and we project that it will continue to pay dividends in the foreseeable future. From a valuation standpoint, UG stock, at the current price of $23, is fully valued. As a result of the ongoing strategic alternatives review, a sale is likely, but we believe that a buyout offer with a significant premium is not likely. There are much cheaper undiscovered names with pristine balance sheets and stronger upside potential.Estimating The Fair Value Of United-Guardian, Inc. (NASDAQ:UG)
How far off is United-Guardian, Inc. ( NASDAQ:UG ) from its intrinsic value? Using the most recent financial data...We Think Shareholders May Want To Consider A Review Of United-Guardian, Inc.'s (NASDAQ:UG) CEO Compensation Package
United-Guardian, Inc. ( NASDAQ:UG ) has not performed well recently and CEO Ken Globus will probably need to up their...Do Investors Have Good Reason To Be Wary Of United-Guardian, Inc.'s (NASDAQ:UG) 5.1% Dividend Yield?
Is United-Guardian, Inc. ( NASDAQ:UG ) a good dividend stock? How can we tell? Dividend paying companies with growing...Should We Be Excited About The Trends Of Returns At United-Guardian (NASDAQ:UG)?
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...Calculating The Fair Value Of United-Guardian, Inc. (NASDAQ:UG)
Today we will run through one way of estimating the intrinsic value of United-Guardian, Inc. ( NASDAQ:UG ) by...United-Guardian's (NASDAQ:UG) Shareholders Are Down 11% On Their Investment Over The Past Five Years.
Ideally, your overall portfolio should beat the market average. But in any portfolio, there will be mixed results...Is The Market Rewarding United-Guardian, Inc. (NASDAQ:UG) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
United-Guardian (NASDAQ:UG) has had a rough three months with its share price down 4.1%. It is possible that the...Our View On United-Guardian's (NASDAQ:UG) CEO Pay
This article will reflect on the compensation paid to Ken Globus who has served as CEO of United-Guardian, Inc...このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、United-Guardian は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。
シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。
業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 3/31/2026 | 11 | 2 | N/A | N/A | N/A |
| 12/31/2025 | 11 | 2 | 2 | 2 | N/A |
| 9/30/2025 | 10 | 2 | 2 | 2 | N/A |
| 6/30/2025 | 11 | 3 | 2 | 2 | N/A |
| 3/31/2025 | 11 | 3 | 3 | 3 | N/A |
| 12/31/2024 | 12 | 3 | 3 | 3 | N/A |
| 9/30/2024 | 12 | 3 | 4 | 4 | N/A |
| 6/30/2024 | 12 | 3 | 4 | 4 | N/A |
| 3/31/2024 | 12 | 3 | 3 | 3 | N/A |
| 12/31/2023 | 11 | 3 | 3 | 3 | N/A |
| 9/30/2023 | 11 | 3 | 3 | 3 | N/A |
| 6/30/2023 | 10 | 2 | 2 | 2 | N/A |
| 3/31/2023 | 11 | 2 | 3 | 3 | N/A |
| 12/31/2022 | 13 | 3 | 2 | 3 | N/A |
| 9/30/2022 | 14 | 3 | 3 | 4 | N/A |
| 6/30/2022 | 14 | 4 | 4 | 4 | N/A |
| 3/31/2022 | 14 | 4 | 4 | 4 | N/A |
| 12/31/2021 | 14 | 5 | 5 | 5 | N/A |
| 9/30/2021 | 13 | 4 | 4 | 4 | N/A |
| 6/30/2021 | 12 | 4 | 3 | 3 | N/A |
| 3/31/2021 | 11 | 4 | 3 | 3 | N/A |
| 12/31/2020 | 11 | 3 | 4 | 4 | N/A |
| 9/30/2020 | 12 | 4 | 4 | 4 | N/A |
| 6/30/2020 | 13 | 4 | 5 | 5 | N/A |
| 3/31/2020 | 14 | 4 | 4 | 4 | N/A |
| 12/31/2019 | 14 | 5 | N/A | 4 | N/A |
| 9/30/2019 | 13 | 4 | N/A | 5 | N/A |
| 6/30/2019 | 13 | 4 | N/A | 5 | N/A |
| 3/31/2019 | 13 | 5 | N/A | 5 | N/A |
| 12/31/2018 | 13 | 4 | N/A | 5 | N/A |
| 9/30/2018 | 14 | 5 | N/A | 5 | N/A |
| 6/30/2018 | 14 | 5 | N/A | 5 | N/A |
| 3/31/2018 | 14 | 4 | N/A | 5 | N/A |
| 12/31/2017 | 13 | 4 | N/A | 4 | N/A |
| 9/30/2017 | 13 | 4 | N/A | 4 | N/A |
| 6/30/2017 | 13 | 3 | N/A | 4 | N/A |
| 3/31/2017 | 11 | 3 | N/A | 2 | N/A |
| 12/31/2016 | 11 | 3 | N/A | 2 | N/A |
| 9/30/2016 | 10 | 2 | N/A | 3 | N/A |
| 6/30/2016 | 10 | 3 | N/A | 3 | N/A |
| 3/31/2016 | 12 | 4 | N/A | 4 | N/A |
| 12/31/2015 | 14 | 5 | N/A | 5 | N/A |
| 9/30/2015 | 16 | 6 | N/A | 6 | N/A |
| 6/30/2015 | 15 | 5 | N/A | 5 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: UGの予測収益成長が 貯蓄率 ( 3.5% ) を上回っているかどうかを判断するにはデータが不十分です。
収益対市場: UGの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です
高成長収益: UGの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。
収益対市場: UGの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。
高い収益成長: UGの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: UGの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です
成長企業の発掘
企業分析と財務データの現状
| データ | 最終更新日(UTC時間) |
|---|---|
| 企業分析 | 2026/05/20 17:48 |
| 終値 | 2026/05/20 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
United-Guardian, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0